Avacta Group Plc (LON:AVCT – Get Free Report)’s stock price reached a new 52-week low during trading on Wednesday . The stock traded as low as GBX 49 ($0.62) and last traded at GBX 49 ($0.62), with a volume of 4167502 shares changing hands. The stock had previously closed at GBX 50.90 ($0.64).
Avacta Group Stock Up 1.5 %
The company has a market capitalization of £174.38 million, a PE ratio of -310.94 and a beta of 1.21. The company has a debt-to-equity ratio of 225.41, a current ratio of 0.71 and a quick ratio of 4.96. The firm has a 50-day simple moving average of GBX 78.21 and a 200 day simple moving average of GBX 110.21.
Avacta Group Company Profile
Avacta Group Plc develops cancer therapies and diagnostics in the United Kingdom, France, North America, South Korea, and rest of Asia and Europe. The company operates through Diagnostics and Therapeutics segments. It develops products based on its proprietary Affimer and pre|CISION technology platforms.
Featured Articles
- Five stocks we like better than Avacta Group
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- Do ETFs Pay Dividends? What You Need to Know
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.
